Long-term renal safety profile of ibandronate 6 mg infused over 15 minutes

von Moos, Roger and Caspar, Clemens B. and Steiner, Rolf and Angst, Rahel and Inauen, Roman and Schmieding, Kerstin and Thürlimann, Beat. (2010) Long-term renal safety profile of ibandronate 6 mg infused over 15 minutes. Onkologie, 33 (8-9). pp. 447-450.

PDF - Published Version

Official URL: http://edoc.unibas.ch/dok/A6002946

Downloads: Statistics Overview


In an earlier study, intravenous (i.v.) ibandronate 6 mg administered every 3-4 weeks had a similarly good renal safety profile whether infused over 15 or 60 min in women with breast cancer and bone metastases. This current study focuses on the renal safety of the extended use of ibandronate.
Faculties and Departments:03 Faculty of Medicine > Bereich Medizinische Fächer (Klinik) > Onkologie
03 Faculty of Medicine > Departement Klinische Forschung > Bereich Medizinische Fächer (Klinik) > Onkologie
UniBasel Contributors:Thürlimann, Beat
Item Type:Article, refereed
Article Subtype:Research Article
Publisher:Karger Publishers
Note:Publication type according to Uni Basel Research Database: Journal article
Related URLs:
Identification Number:
edoc DOI:
Last Modified:24 Oct 2017 10:05
Deposited On:21 Jun 2013 12:24

Repository Staff Only: item control page